Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Falini

Showing results (221-230 of 228) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 228 results.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Leukemia|December 16, 2006
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patientsS A Pileri, S Ascani, M C Cox, et al.
Pathologica|June 23, 2006
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]M Paulli, T Artusi, C D Baroni, et al.
Blood|June 25, 1999
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patientsP L Zinzani, S Storti, A Zaccaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patientsP L Zinzani, F Gherlinzoni, S Storti, et al.
Leukemia|December 13, 2005
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AMLB Falini, B Bigerna, A Pucciarini, et al.
Histopathology|July 18, 2002
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 casesS A Pileri, T M Grogan, N L Harris, et al.
Leukemia|December 24, 2014
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocationF Abate, M Todaro, J-A van der Krogt, et al.
Pageof 23

Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Leukemia|December 16, 2006
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patientsS A Pileri, S Ascani, M C Cox, et al.
Pathologica|June 23, 2006
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]M Paulli, T Artusi, C D Baroni, et al.
Blood|June 25, 1999
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patientsP L Zinzani, S Storti, A Zaccaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patientsP L Zinzani, F Gherlinzoni, S Storti, et al.
Leukemia|December 13, 2005
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AMLB Falini, B Bigerna, A Pucciarini, et al.
Histopathology|July 18, 2002
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 casesS A Pileri, T M Grogan, N L Harris, et al.
Leukemia|December 24, 2014
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocationF Abate, M Todaro, J-A van der Krogt, et al.
Pageof 23